TeleTrader 9/1/2021 Merck announces phase 3 study of its COVID-19 drug
GlobeNewswire 8/18/2021 Telix and Merck to Commence Pan-Cancer Clinical Combination Studies
GlobeNewswire 8/18/2021 Telix and Merck KGaA, Darmstadt, Germany, to Commence Pan-Cancer Clinical Combination Studies
GlobeNewswire 8/5/2021 NGM Bio Provides Business Highlights and Reports Second Quarter 2021 Financial Results
GlobeNewswire 8/4/2021 F-star Therapeutics Announces Collaboration with MSD to Evaluate FS120 in Combination with KEYTRUDA
TeleTrader 7/29/2021 Merck's Q2 revenue tops estimates at $11.40 billion
GlobeNewswire 7/12/2021 Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio
GlobeNewswire 7/1/2021 NGM Amends Collaboration with Merck to Focus Primarily on Advancing Novel Medicines for Retinal and ...
TeleTrader 6/9/2021 Merck, US govt sign deal on oral COVID treatment
TeleTrader 6/2/2021 Germany to increase jab supply to prevent future pandemics
GlobeNewswire 6/1/2021 Immutep Enters Into A New Collaboration With Merck KGaA, Darmstadt, Germany For LAG-3 Therapy, Efti
GlobeNewswire 5/6/2021 NGM Bio Provides Business Highlights and Reports First Quarter 2021 Financial Results
TeleTrader 4/29/2021 Merck misses estimates with $12.1B revenue in Q1
TeleTrader 4/15/2021 Merck to scrap COVID drug for hospitalized patients
GlobeNewswire 4/15/2021 Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin...
GlobeNewswire 4/13/2021 NKMax and Merck KGaA, Darmstadt, Germany Expand Clinical Collaboration to Include Phase I/IIa Trial ...
GlobeNewswire 4/8/2021 Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line...
GlobeNewswire 4/7/2021 PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combi...
GlobeNewswire 4/1/2021 F-star Therapeutics Announces Third Option Exercised by Merck KGaA, Darmstadt, Germany in Immuno-Onc...
GlobeNewswire 3/18/2021 Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
GlobeNewswire 3/16/2021 Immutep Enters Second Collaboration With MSD For A New Randomised Phase IIB Trial In Head And Neck C...
TeleTrader 3/15/2021 Gilead, Merck jointly developing new HIV drug
TeleTrader 3/10/2021 J&J to deliver additional 100M doses in H2 - WH
GlobeNewswire 3/9/2021 Apollomics, Inc. Appoints Seasoned Healthcare Executive K. Peony Yu, M.D., as Chief Medical Officer
TeleTrader 3/6/2021 COVID-19 drug efficient in reducing infection after 5 days - trial